Mitoxantrone Injection USP (2015-08-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| B024636AAR | Mitoxantrone Injection USP | - Recalling Firm
- Hospira Healthcare Corporation
- 2600 Alfred Nobel Blvd, Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation
- 2600 Alfred Nobel Blvd, Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
| Solution | DIN 02244614 | Mitoxantrone 2 mg/mL |
Affected Products
Mitoxantrone Injection USP
Product may not support the specification results for known impurity prior to expiry.
Hospitals (Including pharmacies)